CompCare's 2011 revenues increase to $71,210,000

Comprehensive Care Corporation ("CompCare") (OTC BB: CHCR), a leading behavioral health, substance abuse and psychotropic pharmacy management services provider for managed care companies throughout the U.S., is pleased to announce that its revenues for 2011 more than doubled to $71,210,000 compared to revenues of $35,214,000 in 2010.

Clark Marcus, CompCare's Chairman and Chief Executive Officer said, "To continue our upward growth momentum amid a changing health care landscape, management believed it was vitally important to improve the Company's margins to levels that would support long-term, sustainable profitability. To achieve that result the Company adopted a growth/profitability strategy of reinvesting its top-line revenues during the 2010 through 2011 period in order to somewhat offset future needs for additional large re-investments moving forward. During this period we successfully streamlined and automated key business functions, expanded and strengthened our provider network, built a solid infrastructure and employee base, and developed ancillary products marketable to both the public and private sectors of health care. As a result of this reinvestment strategy, we believe the Company is extremely well positioned to absorb anticipated additional new business."

"The increase in our revenue, we believe, validates the dedicated efforts of our board of directors and our management and support teams. We intend to continue to strengthen our national provider panel, develop additional innovative solutions to combat the upward spiraling cost of health care and leverage our existing expertise to address these health care trends. For example, the increasing elderly demographic nationwide, we believe, presents an opportunity for us to capitalize on our Medicare solutions. In addition, if the governmental mandates for health care are established, a greater number of people will be covered by health insurance. With these trends comes an increasing demand for behavioral health and pharmacy solutions. We believe that we are well positioned to capitalize on these trends."

"One of our primary focus points over the last two years has been the development of an at-risk pharmacy program designed to materially reduce pharmacy costs to health plans and self-insureds. Prescription drugs represent approximately 10% of overall health care expenditures. We are confident that the innovative pharmacy plan developed by the Company can reduce these costs by up to 10%, which sets us substantially apart from the pack. We are so confident in this program that we are prepared to go at-risk on our clients pharmacy spend for as much as 10% below their previous year pharmacy expenditure. Our affiliations with a major retailer and a major Pharmacy Benefit Manager ("PBM") provide the underpinnings to facilitate this program, which we have now begun to aggressively market. Management believes that the Company's at-risk pharmacy program provides the Company with an important competitive edge in the market place; will eventually result in the national reduction of pharmacy costs in both the private and commercial sectors and will result in high margin, profitable revenue, for the Company, long term,"  Mr. Marcus said.